Search results
-
Novartis: el liderazgo de una empresa global
George, William W.; Palepu, Krishna G.; Knoop, Carin-IsabelCase HBS-418S09StrategyNovartis, empresa de salud más importantes del mundo, se formó en 1996 de la fusión de dos compañías farmacéuticas muy diferente, de nivel medio con sede en Suiza. El caso describe la evolución de la compañía durante los últimos 17 años, ya que se transformó en una empresa verdaderamente global, con 127.000 empleados de 153 nacionalidades en 140 países y generando $ 56,7 mil millones en 2012 ingresos y $ 9.6 mil millones en ingresos netos, por lo...Starting at €8.20
-
Novartis: Leading a Global Enterprise
George, William W.; Palepu, Krishna G.; Knoop, Carin-IsabelCase HBS-413096-ENovartis, the world's leading healthcare company, was formed in 1996 out of a merger of two very different, mid-tier Switzerland-based pharma companies. The case traces the company's evolution over the past 17 years, as it transformed into a truly global enterprise with 127,000 employees of 153 nationalities in 140 countries generating $56.7 billion in 2012 revenues and $9.6 billion in net income, making the firm one of the world's largest and mo...Starting at €8.20
-
Emilio Sastre
Gallo, Miguel Ángel; Mozo, EnriqueCase DG-1007-EStrategyThis case describes some of the directions taken by an MED student in the first few years of his career, following his incorporation into a family group of companies. It explains the process by which he joins the group, the problems he faces with an established manager who he has to work with, his "inclusion" in the family and in the higher levels of power, the birth of his "psychological contract" with the company, and its subsequent repercussio...Starting at €8.20
-
Emilio Sastre
Gallo, Miguel Ángel; Mozo, EnriqueCase DG-1007StrategyEl caso describe las distintas orientaciones por las que atraviesa un alumno del MED en los primeros años de su carrera profesional, tras su entrada en un grupo de empresas familiar. Se relata su proceso de incorporación, sus dificultades con un antiguo directivo en quien tiene que apoyarse, su «inclusión» en la familia y cúpula de poder, el nacimiento de su «contrato psicológico» con la empresa, y la consiguiente repercusión en el planteamiento ...Starting at €8.20
-
Grupo Pires
Gallo, Miguel Ángel; Gallo, R.; Mozo, EnriqueCase DG-1061StrategyPresenta a un grupo de empresas portuguesas de propiedad familiar dedicadas al sector de la confección, y describe la historia del grupo desde sus inicios, con la primera empresa de confección de camisas, hasta el impresionante crecimiento posterior que le ha llevado a ser el mayor grupo empresarial del sector. El caso se sitúa temporalmente después de la muerte repentina del hijo del fundador de la empresa, que estaba a la cabeza del grupo, y se...Starting at €8.20
-
Medtronic: Making the Big Leap Forward (A)
George, William W.; Baraldi, MonicaCase HBS-317031-EStrategyIn 2014, Medtronic was about to execute a $50 billion acquisition of Ireland-based Covidien. Medtronic CEO Omar Ishrak was committed to building the largest medical technology company in the world while broadening its ability to fulfill its mission of "alleviating pain, restoring health, and extending life" for millions more patients every year. The acquisition plan might change when, in September 2014, U.S. Secretary Jacob Lew issued new rules f...Starting at €8.20
-
Royal DSM: From Continuous Transformation to Organic Growth
George, William W.; Knoop, Carin-Isabel; Migdal, AmramCase HBS-317063-EStrategyRoyal DSM CEO Feike Sijbesma was pondering the challenges of shifting DSM's global organization from the constant transformations of the past 100 years to creating organic growth. When Sijbesma took the helm as CEO in 2007, he further pushed and completed the company's final moves away from commodity chemicals and toward more sustainable businesses whereby DSM could create value with differentiated offerings. Sijbesma emphasized innovation and mo...Starting at €8.20
-
Medtronic: Making the Big Leap Forward (B)
George, William W.; Baraldi, MonicaCase HBS-317074-EStrategyOn December 1, 2014, Medtronic announced that it had completed a $17 billion bond sale to finance the Covidien acquisition, officially completed on January 26, 2015. Medtronic's legal headquarters moved to Ireland, while its operational headquarters remained in Minneapolis, Minnesota. In this case study, Medtronic CEO Omar Ishrak reflects back on the integration progress since the deal's completion and offers his perspective as a global leader.Starting at €5.74